Recipients

Why do cancer therapies often fail? Recent evidence suggests it may be because they don’t attack the root of the problem – cancer stem cells that regenerate tumours and spread disease to other locations in the body.
The Cancer Stem Cell Initiative is working to find out how cancer stem cells differ from normal stem cells, and how these differences might be exploited for new, more effective and less toxic treatments. A major part of the initiative will be to harness the Canadian Light Source synchrotron to improve methods of imaging tumours and to help develop inhibitors that target cancer stem cells.

< Back to Search Results